SCHEMBL8323249

SCHEMBL8323249

COCc1nc(NS(=O)(=O)c2ccc3c(c2)OCO3)c(Oc2cc(OC)ccc2Cl)c(OCCOC(=O)Nc2ccccn2)n1

nearest known ligand 0.55

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
EDNRA P25101 20/20 0.55
EDNRB P24530 19/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8324911 0.95 EDNRA (0.56) EDNRAEDNRB
SCHEMBL8328509 0.94 EDNRA (0.55) EDNRAEDNRB
SCHEMBL9090723 0.92 EDNRA (0.52) EDNRAEDNRB
SCHEMBL8326972 0.92 EDNRA (0.53) EDNRAEDNRB
SCHEMBL9091048 0.90 EDNRA (0.55) EDNRAEDNRB
SCHEMBL9092273 0.90 EDNRA (0.52) EDNRAEDNRB
SCHEMBL8322713 0.90 EDNRA (0.51) EDNRAEDNRB
SCHEMBL9091652 0.89 EDNRA (0.50) EDNRAEDNRB
SCHEMBL8322625 0.88 EDNRA (0.70) EDNRAEDNRB
SCHEMBL8325841 0.88 EDNRA (0.45) EDNRAEDNRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0633259-B1 Sulfonylaminopyrimidines, their preparation and their use as medicine HOFFMANN LA ROCHE (CH) 1999-01-13 EP claimed
EP-0633259-A1 Sulfonylaminopyrimidines, their preparation and their use as medicine F. HOFFMANN-LA ROCHE AG (CH) 1995-01-11 EP claimed
EP-0633259-B1 Sulfonylaminopyrimidines, their preparation and their use as medicine HOFFMANN LA ROCHE (CH) 1999-01-13 EP disclosed
US-5541186-A ENDOTHELIN RECEPTOR INHIBITORS HOFFMANN-LA ROCHE INC. (US) 1996-07-30 US disclosed
EP-0633259-A1 Sulfonylaminopyrimidines, their preparation and their use as medicine F. HOFFMANN-LA ROCHE AG (CH) 1995-01-11 EP disclosed